UBS
UC94.L
LU1169830442
UBS MSCI Switzerland 20/35 UCITS ETF hGBP dis
Loading chart...

Analytics & Allocation

Detailed breakdown by growth drivers, valuation & quality, and asset allocation

Growth Drivers (Estimates)

Largest contributors to earnings and revenue growth

Balance Sheet & Financial Health

Aggregated leverage and valuation structure

Weighted P/E
24.38
Weighted Fwd P/E
15.57
Avg P/FCF
27.56
Avg FCF Yield
1.83%
Avg EV / EBITDA
15.67
Avg EV / Revenue
4.1
Avg Price-to-Book (P/B)
6.4
Avg Price-to-Sales (P/S)
3.66
Avg Dividend Yield
0.01%
P/E Compression (Trailing vs Fwd)
-36.12%
Avg Debt-to-Equity (D/E)
107.18%
<50% (15.68%) 50-150% (57.66%) >150% (17.63%) Unreported (9.03%)

Profitability Analysis

39 Holdings Count
Profitable 100%
Profitable 100%
39 Holdings Count (100%)
Unprofitable 0%
0 Holdings Count (0%)

ETF Concentration (Cumulative Weight)

Cumulative weight of positions (Lorenz curve)

High Concentration (Top-Heavy)
Top 5
56.4%
Top 10
74.7%
Top 25
92.9%
50% Threshold
Top 5
The top 10 holdings account for 74.7% of the total ETF. Performance is heavily driven by a few heavyweights. The steeper the curve initially rises, the more the largest positions dominate the fund volume.

Geographic Distribution

1 Countries
Loading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (24.7%+)
High (64.2%+)
Top (88.9%+)

Country Breakdown

Max: 98.82%
CH CH CH
98.82%

Sector Distribution

10 Sector
Healthcare
37.46%
Financial Services
20.13%
Consumer Defensive
13.80%
Industrials
12.68%
Consumer Cyclical
6.45%
Basic Materials
5.88%
Other
2.41%

Industry Distribution

25 Industries
Drug Manufacturers - General
28.50%
Packaged Foods
12.98%
Insurance - Diversified
7.98%
Banks - Diversified
7.81%
Electrical Equipment & Parts
7.73%
Luxury Goods
6.16%
Drug Manufacturers - Specialty & Generic
3.66%
Specialty Chemicals
3.65%
Other
20.34%

Market Cap Distribution

39 Holdings Count
Mega Cap (> 200B)
(4) 41.47%
Large Cap (10B - 200B)
(31) 56.30%
Mid Cap (2B - 10B)
(4) 1.04%
ende